0000899243-22-020399.txt : 20220601 0000899243-22-020399.hdr.sgml : 20220601 20220601162319 ACCESSION NUMBER: 0000899243-22-020399 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220527 FILED AS OF DATE: 20220601 DATE AS OF CHANGE: 20220601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Michael Edward L. CENTRAL INDEX KEY: 0001391823 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 22987650 MAIL ADDRESS: STREET 1: 618 SHERIDAN SQUARE CITY: EVANSTON STATE: IL ZIP: 60202 FORMER NAME: FORMER CONFORMED NAME: Michael Edward L DATE OF NAME CHANGE: 20070301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-27 1 0000353569 QUIDEL CORP /DE/ QDEL 0001391823 Michael Edward L. 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 1 0 0 0 Common Stock 2022-05-27 4 D 0 9098 D 0 D Restricted Stock Units 2022-05-27 4 D 0 1137 0.00 D Common Stock 1137 0 D Restricted Stock Units 2022-05-27 4 D 0 341 0.00 D Common Stock 341 0 D Restricted Stock Units 2022-05-27 4 D 0 356 0.00 D Common Stock 356 0 D Restricted Stock Units 2022-05-27 4 D 0 106 0.00 D Common Stock 106 0 D Restricted Stock Units 2022-05-27 4 D 0 555 0.00 D Common Stock 555 0 D Restricted Stock Units 2022-05-27 4 D 0 166 0.00 D Common Stock 166 0 D Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho. Each restricted stock unit represents the right to receive one share of Quidel common stock. Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. /s/ Phillip S. Askim, attorney-in-fact for Edward L. Michael 2022-06-01